Search results
Share market update: Most active stocks on D-Street today in terms of volume
The Economic Times· 1 day agoThe NSE Nifty index was trading 97.5 points up at 24384.0
LIC raises stake in IDFC First Bank to 2.68% at ₹80.63/share via private placement offer | Mint
Livemint· 22 hours agoLIC raised its stake in IDFC First Bank to 2.68% at ₹80.63 per share via a private placement offer...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 21 hours agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Niva Bupa Health Insurance files draft papers with Sebi to launch Rs 3,000 crore IPO
Business Today· 4 days agoNiva Bupa Health Insurance is one of largest and fastest growing standalone retail health insurers...
Bain Capital-backed Emcure Pharma mobilises Rs 583 Cr from anchor investors
YourStory· 2 days ago...Prudential MF, SBI MF, Nippon India MF, Abu Dhabi Investment Authority, Goldman Sachs Asset Management, Nomura, HDFC Life Insurance Company, ICICI Prudential Life Insurance Company and, SBI Life Insurance Company.
Macquarie Capital rates HDFC Bank a 'buy', sees this potential near-term trigger - CNBC TV18
CNBC TV18· 3 days agoSuresh Ganapathy, banking analyst at Macquarie Capital Securities expressed a cautious stance on ...
Bajaj Finance can become best pick in financial space amongst largecaps in one or two quarters:...
The Economic Times· 23 hours agoWhatever growth will pick up will probably happen on the infra corporate side. HDFC is not known to...
Stock market update: Power stocks down as market rises
The Economic Times· 1 day agoThe 30-share BSE Sensex was up 127.33 points at 80114.13
Market cap tracker: Reliance, HDFC Bank gain most among Top 10 post-election; LIC, ITC lose
The Week· 4 days agoAmong the Top 10 companies, Reliance Industries saw the most gains, along with seven other firms. ...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 1 day agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...